Literature DB >> 29517078

Depression, Obstructive Sleep Apnea and Psychosocial Health.

Shazia Jehan1, Evan Auguste2, Seithikurippu R Pandi-Perumal3, Jolaade Kalinowski1, Alyson K Myers4, Ferdinand Zizi1, Madhu G Rajanna5, Girardin Jean-Louis1, Samy I McFarlane4.   

Abstract

Depression and Obstructive sleep apnea (OSA) are the major associated comorbidities. OSA is a rapidly growing problem in the society that is connected to the rising rates of obesity; at the same time, the depression rate is also increasing day by day. Patients with OSA present with sleep problems, anxiety, and depressive symptoms, depressive patients can also present with the same symptoms. The quality of an individual's health can be improved by the early detection of the symptoms of overlapping OSA and depression. By addressing these issues early, the associated healthcare costs and burden can be reduced simultaneously.

Entities:  

Keywords:  CPAP; Depression; Natriuretic peptide; OSA; Psychosocial; Sleep

Year:  2017        PMID: 29517078      PMCID: PMC5836734     

Source DB:  PubMed          Journal:  Sleep Med Disord        ISSN: 2577-8285


  90 in total

1.  Self-reported obstructive sleep apnea is associated with nonresponse to antidepressant pharmacotherapy in late-life depression.

Authors:  Lauren Waterman; Sarah T Stahl; Daniel J Buysse; Eric J Lenze; Daniel Blumberger; Benoit Mulsant; Meryl Butters; Marie Anne Gebara; Charles F Reynolds; Jordan F Karp
Journal:  Depress Anxiety       Date:  2016-09-16       Impact factor: 6.505

2.  Serial electrocardiogram changes in acute tricyclic antidepressant overdoses.

Authors:  E L Liebelt; A Ulrich; P D Francis; A Woolf
Journal:  Crit Care Med       Date:  1997-10       Impact factor: 7.598

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

Review 4.  Sleep-disordered breathing and cardiovascular disease.

Authors:  Barbara Phillips
Journal:  Sleep Med Rev       Date:  2005-04       Impact factor: 11.609

5.  Depression, physical activity, energy consumption, and quality of life in OSA patients before and after CPAP treatment.

Authors:  C Diamanti; E Manali; M Ginieri-Coccossis; K Vougas; K Cholidou; E Markozannes; P Bakakos; I Liappas; M Alchanatis
Journal:  Sleep Breath       Date:  2013-02-06       Impact factor: 2.816

6.  Personality, anxiety and mood traits in patients with sleep-related breathing disorders: effect of reduced daytime alertness.

Authors:  Emilia Sforza; Zara de Saint Hilaire; Antoine Pelissolo; Thierry Rochat; Vincent Ibanez
Journal:  Sleep Med       Date:  2002-03       Impact factor: 3.492

Review 7.  Evidence for an immune response in major depression: a review and hypothesis.

Authors:  M Maes
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1995-01       Impact factor: 5.067

8.  Neural alterations and depressive symptoms in obstructive sleep apnea patients.

Authors:  Rebecca L Cross; Rajesh Kumar; Paul M Macey; Lynn V Doering; Jeffry R Alger; Frisca L Yan-Go; Ronald M Harper
Journal:  Sleep       Date:  2008-08       Impact factor: 5.849

Review 9.  Risk of QT/QTc prolongation among newer non-SSRI antidepressants.

Authors:  Natalia M Jasiak; Jolene R Bostwick
Journal:  Ann Pharmacother       Date:  2014-09-09       Impact factor: 3.154

Review 10.  Changes in comorbidities and improvements in quality of life after LAP-BAND placement.

Authors:  John B Dixon; Paul E O'Brien
Journal:  Am J Surg       Date:  2002-12       Impact factor: 2.565

View more
  6 in total

1.  Assessing Depression and Suicidality Among Recently Unemployed Persons with Obstructive Sleep Apnea and Socioeconomic Inequality.

Authors:  Vijay Singh; Patricia L Haynes; Stuart F Quan
Journal:  Southwest J Pulm Crit Care Sleep       Date:  2022-05-16

2.  Sleep apnea and the impact on cardiovascular risk in patients with Marfan syndrome.

Authors:  Laura Muiño-Mosquera; Fré Bauters; Karlien Dhondt; Hans De Wilde; Luc Jordaens; Katya De Groote; Daniel De Wolf; Katrien Hertegonne; Julie De Backer
Journal:  Mol Genet Genomic Med       Date:  2019-06-27       Impact factor: 2.183

3.  GCH1 (rs841) polymorphism in the nitric oxide-forming pathway has protective effects on obstructive sleep apnea.

Authors:  Samaneh Sheikhi Kouhsar; Mohammadreza Bigdeli; Yadollah Shakiba; Khosro Sadeghniiat
Journal:  Sci Rep       Date:  2019-12-09       Impact factor: 4.379

4.  Effect of Obstructive Sleep Apnea on the Risk of Injuries-A Nationwide Population-Based Cohort Study.

Authors:  An-Che Cheng; Gwo-Jang Wu; Chi-Hsiang Chung; Kuo-Hsiang Wu; Chien-An Sun; I-Duo Wang; Wu-Chien Chien
Journal:  Int J Environ Res Public Health       Date:  2021-12-20       Impact factor: 3.390

Review 5.  Disruption of Circadian Rhythm Genes in Obstructive Sleep Apnea Patients-Possible Mechanisms Involved and Clinical Implication.

Authors:  Agata Gabryelska; Szymon Turkiewicz; Filip Franciszek Karuga; Marcin Sochal; Dominik Strzelecki; Piotr Białasiewicz
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

Review 6.  Matrix metalloproteinase-9 as a messenger in the cross talk between obstructive sleep apnea and comorbid systemic hypertension, cardiac remodeling, and ischemic stroke: a literature review.

Authors:  Saif Mashaqi; Heidi M Mansour; Hanan Alameddin; Daniel Combs; Salma Patel; Lauren Estep; Sairam Parthasarathy
Journal:  J Clin Sleep Med       Date:  2021-03-01       Impact factor: 4.062

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.